🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of ...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-11-12
Trial ID
NCT07241767
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University
Start Date
2025-07-08
Trial ID
NCT07028281
Treatments Being Tested
This study is an open-label, multicenter Phase II clinical trial to evaluat...
Status
Recruiting
Location
Chinese People's Liberation Army (PLA) General Hospital
Start Date
2025-03-07
Trial ID
NCT06844474
Treatments Being Tested
This study is a multicentre, open-label, dose-finding/efficacy-expanding ph...
Status
Recruiting
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Start Date
2025-04-25
Trial ID
NCT06859775
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-11-04
Trial ID
NCT06639347
Treatments Being Tested
This study is a multicenter, open-label, dose-finding/efficacy-expanding Ph...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2024-09-27
Trial ID
NCT06589778
Treatments Being Tested
Cohort A and B: This cohort aims to evaluate the efficacy and safety of SHR...
Status
Active Not Recruiting
Location
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Start Date
2024-07-01
Trial ID
NCT06465563
Treatments Being Tested
This is an open label, multi-center, multiple dose Phase IB/II study to eva...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2025-02-18
Trial ID
NCT06754930
Treatments Being Tested
Objective response rate (ORR) was evaluated to evaluate the efficacy of SHR...
Status
Active Not Recruiting
Location
Chinese PLA General Hospital
Start Date
2024-03-11
Trial ID
NCT06247956
THis study aims to evaluate the efficacy of SHR-8068 combined with Adebreli...
Status
Recruiting
Location
Anhui Provincial Hospital
Start Date
2024-10-28
Trial ID
NCT06618664
Treatments Being Tested